Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob/ob mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob/ob mice
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-11-24
DOI
10.1093/ndt/gfab330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consistent Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Irrespective of Diabetic Kidney Disease Categories – Insights from the EMPA‐REG OUTCOME trial
- (2020) Christoph Wanner et al. DIABETES OBESITY & METABOLISM
- Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
- (2020) Manga Motrapu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism
- (2020) Laura Senatus et al. JCI Insight
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats
- (2020) Juliane D. Glaeser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual lineage tracing shows that glomerular parietal epithelial cells can transdifferentiate towards the adult podocyte fate
- (2019) Natalya V. Kaverina et al. KIDNEY INTERNATIONAL
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute and Direct Effects of Sodium–Glucose Cotransporter 2 Inhibition on Glomerular Filtration Rate in Spontaneously Diabetic Torii Fatty Rats
- (2019) Shoji Takakura et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Reactive Carbonyl Species: Diabetic Complication in the Heart and Lungs
- (2019) Cheng-ju Tian et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
- (2018) Radica Z. Alicic et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review
- (2018) Radica Z. Alicic et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
- (2018) Hiddo J.L. Heerspink et al. KIDNEY INTERNATIONAL
- Sodium–glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice
- (2018) Shinji Tanaka et al. KIDNEY INTERNATIONAL
- Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
- (2018) Michitsugu Kamezaki et al. Scientific Reports
- Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
- (2018) Christoph Wanner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion
- (2017) Sebastian S. Roeder et al. KIDNEY INTERNATIONAL
- Diabetes and Kidney Disease: Role of Oxidative Stress
- (2016) Jay C. Jha et al. ANTIOXIDANTS & REDOX SIGNALING
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis
- (2015) Diana G. Eng et al. KIDNEY INTERNATIONAL
- The phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy
- (2015) Nicole K. Andeen et al. KIDNEY INTERNATIONAL
- Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Nephrology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of CD44-Positive Glomerular Parietal Epithelial Cells Reflects Podocyte Injury in Adriamycin Nephropathy
- (2014) Takayuki Okamoto et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Estimating Podocyte Number and Density Using a Single Histologic Section
- (2013) M. Venkatareddy et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Reversibility of Structural and Functional Damage in a Model of Advanced Diabetic Nephropathy
- (2013) W. Pichaiwong et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Parietal Epithelial Cell Activation Marker in Early Recurrence of FSGS in the Transplant
- (2012) H. Fatima et al. Clinical Journal of the American Society of Nephrology
- Mouse models of diabetic nephropathy
- (2011) Charles E Alpers et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
- (2010) V. Vallon et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- BTBR Ob/Ob Mutant Mice Model Progressive Diabetic Nephropathy
- (2010) K. L. Hudkins et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mouse Models of Diabetic Nephropathy
- (2009) F. C. Brosius et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Protease Nexin-1, tPA, and PAI-1 are Upregulated in Cryoglobulinemic Membranoproliferative Glomerulonephritis
- (2008) S. Taneda et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis
- (2008) Jeroen K.J. Deegens et al. KIDNEY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started